RecruitingPhase 4NCT04144439
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.
Sponsor
Sherief Abd-Elsalam
Enrollment
30 participants
Start Date
Jul 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Effect of GABA on ADHD and seizures in Children with epilepsy.
Eligibility
Min Age: 4 YearsMax Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called GABA for people with epilepsy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 4 Years to 18 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGGABA
Gamma amino butyric acid
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04144439
Related Trials
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
NCT075638815 locations
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
NCT066239941 location
Surgery as a Treatment for Medically Intractable Epilepsy
NCT012731291 location
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
NCT021079891 location
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
NCT025318801 location